| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |